Yahoo Web Search

Search results

1. • Q1 2024 Scientific Industries Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 5 days ago

     Our legacy CGQ products remain in high demand, which enabled us to sell our inventory at an average gross margin of around 63%. At the same time, we shipped...customer trials ...

2. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 8 hours ago

     PEGylated Proteins Market: Driving Innovations in Therapeutic Solutions PR Newswire BOSTON, May 22, 2024 In-depth study of PEGylated Protein market dynamics and growth trends. From improved ...

3. • Revolutionizing Cannabis Extraction: ENTEXS Unveils Groundbreaking Ethanol Extraction Platform With...

     Digital Journal· 6 days ago

     For more information about the ENTEXS Ethanol Extraction Platform with...AI Alliance CoTec Holdings Corp. Subsidiary HyProMag USA LLC. to Benefit from USA 25% Tariff on Permanent ...

4. • Telix Files Registration Statement for Proposed Initial Public Offering in the United States

     Benzinga· 5 days ago

     Telix Pharmaceuticals Limited TLX Telix, the Company) today announces that it has filed a registration statement on Form F-1 (Registration Statement) with the United States ...

5. • 

     The price of hope: CAR-T therapy in pediatric leukemia

     Medical Xpress· 2 days ago

     We stand at the crossroads of medical innovation, where cutting-edge scientific discoveries...

6. • Q3 2024 Palatin Technologies Inc Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 6 days ago

     This clinical study will support the development program for a combination product which is a Co-Formulation of Bremelanotide with a [phosphodiesterase- ...

7. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 7 days ago

     SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives

8. • IRLAB has Administered the First Dose in a Phase I Clinical Trial with the Drug Candidate IRL757

     Morningstar· 5 hours ago

     GOTHENBURG, SWEDEN / ACCESSWIRE / May 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, May 22, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering ...

9. • Lisata Therapeutics (NASDAQ:LSTA) Stock Rating Reaffirmed by HC Wainwright

     ETF DAILY NEWS· 1 day ago

     Lisata Therapeutics (NASDAQ:LSTA – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a research note issued to investors on Tuesday, Benzinga ...

10. • 

      Latham and Arnold & Porter Build Health Care Regulatory Teams | National Law Journal

      Law.com· 1 day ago

      Health care regulatory and enforcement practices are continuing to drive lateral moves in...